Phase II Trial of Lenalidomide - Rituximab ± Dexamethasone in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab

被引：0
作者：
Ahmadi, Tahamtan
Chong, Elise A. [1 ]
Gordon, Amanda [1 ]
Aqui, Nicole A. [2 ]
Xu, YinYan [2 ]
Svoboda, Jakub [1 ]
Nasta, Sunita D. [1 ]
Schuster, Stephen J. [1 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [11] A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma
    Qingyuan Zhang
    Rong Tao
    Zhenyu Li
    Haiyi Guo
    Meng Ji
    Lu Zhang
    Jane Huang
    Fu Lina
    Jinhua Zhong
    Jianfeng Zhou
    LEUKEMIA & LYMPHOMA, 2022, 63 (10) : 2503 - 2506
  • [12] Results of a Phase II trial of gemcitabine, mitoxantrone, and rituximab in relapsed or refractory mantle cell lymphoma
    Lawrence E. Garbo
    Patrick J. Flynn
    Margaret A. MacRae
    Mary A. Rauch
    Yunfei Wang
    Kathryn S. Kolibaba
    Investigational New Drugs, 2009, 27 : 476 - 481
  • [13] Results of a Phase II trial of gemcitabine, mitoxantrone, and rituximab in relapsed or refractory mantle cell lymphoma
    Garbo, Lawrence E.
    Flynn, Patrick J.
    MacRae, Margaret A.
    Rauch, Mary A.
    Wang, Yunfei
    Kolibaba, Kathryn S.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (05) : 476 - 481
  • [14] Increased Dose Rituximab Followed by Maintenance Rituximab As Initial Therapy for Indolent B Cell Lymphomas: A Phase II Trial
    Barnes, Jeffrey A.
    Stevenson, Kristen
    Hochberg, Ephraim P.
    Takvorian, Tak
    Fisher, David C.
    LaCasce, Ann
    Brown, Jennifer R.
    Mahindra, Anuj K.
    Neuberg, Donna
    Abramson, Jeremy S.
    BLOOD, 2011, 118 (21) : 1587 - 1588
  • [15] German experience with bendamustine treating Relapsed/Refractory indolent B-Cell and mantle cell lymphomas
    Rummel, Mathias J.
    SEMINARS IN HEMATOLOGY, 2007, 44 (03) : S22 - S26
  • [16] Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Gandolfi, Letizia
    Stefoni, Vittorio
    Quirini, Federica
    Derenzini, Enrico
    Broccoli, Alessandro
    Argnani, Lisa
    Pileri, Stefano
    Baccarani, Michele
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06) : 462 - 466
  • [17] Prolonged Lymphocytepenia after Bendamustine with or without Rituximab Treatment in Patients with Relapsed or Refractory Indolent B-Cell and Mantle Cell Lymphoma
    Saito, Hideaki
    Maruyama, Dai
    Maeshima, Akiko Miyagi
    Makita, Shin-ichi
    Kitahara, Hideaki
    Miyamoto, Ken-ichi
    Fukuhara, Suguru
    Munakata, Wataru
    Suzuki, Tatsuya
    Kobayashi, Yukio
    Taniguchi, Hirokazu
    Tobinai, Kensei
    BLOOD, 2014, 124 (21)
  • [18] A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study
    Kimihiro Matsumoto
    Nobuyuki Takayama
    Yoshinobu Aisa
    Hironori Ueno
    Masao Hagihara
    Kentaro Watanabe
    Aya Nakaya
    Kenko Chen
    Takayuki Shimizu
    Yuiko Tsukada
    Yuji Yamada
    Tomonori Nakazato
    Akaru Ishida
    Yoshitaka Miyakawa
    Kenji Yokoyama
    Hideaki Nakajima
    Yoshihiro Masuda
    Takahiro Yano
    Shinichiro Okamoto
    International Journal of Hematology, 2015, 101 : 554 - 562
  • [19] A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study
    Matsumoto, Kimihiro
    Takayama, Nobuyuki
    Aisa, Yoshinobu
    Ueno, Hironori
    Hagihara, Masao
    Watanabe, Kentaro
    Nakaya, Aya
    Chen, Kenko
    Shimizu, Takayuki
    Tsukada, Yuiko
    Yamada, Yuji
    Nakazato, Tomonori
    Ishida, Akaru
    Miyakawa, Yoshitaka
    Yokoyama, Kenji
    Nakajima, Hideaki
    Masuda, Yoshihiro
    Yano, Takahiro
    Okamoto, Shinichiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (06) : 554 - 562
  • [20] Bendamustine and rituximab act synergistically in vitro and are effective in the treatment of relapsed or refractory indolent and mantle cell lymphomas.
    Rummel, MJ
    Al-Bartran, S
    Welslau, M
    Kofahl-Krause, D
    Duerk, H
    Hoelzer, D
    Mitrou, PS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 576S - 576S
12345